Progress in regulating inflammatory biomaterials for intervertebral disc regeneration

Intervertebral disc degeneration(IVDD)is rising worldwide and leading to significant health issues and financial strain for patients.Traditional treatments for IVDD can alleviate pain but do not reverse disease progression,and surgical removal of the damaged disc may be required for advanced disease.The inflammatory microenvironment is a key driver in the development of disc degeneration.Suitable anti-inflammatory substances are critical for controlling inflammation in IVDD.Several treatment options,including glucocorticoids,non-steroidal anti-inflammatory drugs,and biotherapy,are being studied for their potential to reduce inflammation.However,anti-inflammatories often have a short half-life when applied directly and are quickly excreted,thus limiting their therapeutic effects.Biomaterial-based platforms are being explored as anti-inflammation therapeutic strategies for IVDD treatment.This review introduces the pathophysiology of IVDD and discusses anti-inflammatory therapeutics and the components of these unique biomaterial platforms as comprehensive treatment systems.We discuss the strengths,shortcomings,and development prospects for various biomaterials platforms used to modulate the inflammatory microenvironment,thus providing guidance for future breakthroughs in IVDD treatment.